Browse by Audience
Skip to content
Papers of the Week
Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation.
Abstract
The application of botulinum toxin type A (BoNTA) is accelerating, and this includes the uncontrolled cosmetic use of the BoNTA. Diffusion of BoNTA can disturb neuromuscular transmission in several surrounding and distant muscles and result in clinical manifestations similar to myasthenia gravis (MG).